New Zealand markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
177.61+3.78 (+2.17%)
At close: 04:00PM EDT
177.62 +0.01 (+0.01%)
After hours: 07:04PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
890,386
897,556
779,437
474,505
621,674
Depreciation & amortisation
214,801
197,562
193,841
191,518
181,373
Stock-based compensation
76,109
71,142
65,257
63,927
57,559
Change in working capital
-130,467
-462,127
-708,076
1,405
-97,921
Accounts receivable
-50,957
-106,511
19,346
-129,195
54,383
Inventory
61,378
-248,833
-311,681
-21,954
-69,881
Accounts payable
-
-
-247,632
210,708
-23,424
Other working capital
943,734
559,299
195,111
619,892
696,317
Other non-cash items
-
-11,050
-
8,673
-7
Net cash provided by operating activities
1,079,116
693,299
351,147
736,718
802,255
Cash flows from investing activities
Investments in property, plant and equipment
-135,382
-134,000
-156,036
-116,826
-105,938
Acquisitions, net
-112,212
-1,012,749
-42,784
-39,067
-27,910
Purchases of investments
-29,358
-32,229
-37,900
-21,788
-46,013
Sales/maturities of investments
12,202
19,133
6,802
19,219
0
Net cash used for investing activities
-264,750
-1,159,845
-229,918
-158,462
-179,861
Cash flows from financing activities
Debt repayment
-675,000
-405,000
-166,000
-612,000
-1,284,012
Common stock issued
44,983
49,142
47,384
37,790
48,182
Common stock repurchased
0
-
-
0
0
Dividends paid
-270,620
-258,276
-245,341
-226,713
-225,093
Other financing activities
-12,594
-32,992
-52,406
-53,709
-46,363
Net cash used provided by (used for) financing activities
-858,238
422,874
-128,363
-764,632
-317,286
Net change in cash
-42,952
-45,819
-21,568
-167,878
316,028
Cash at beginning of period
253,199
273,710
295,278
463,156
147,128
Cash at end of period
209,327
227,891
273,710
295,278
463,156
Free cash flow
Operating cash flow
1,079,116
693,299
351,147
736,718
802,255
Capital expenditure
-135,382
-134,000
-156,036
-116,826
-105,938
Free cash flow
943,734
559,299
195,111
619,892
696,317